Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-2021015
  • Global CRISPR Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: May 2017 | Report Code: HBI-2021015

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

The Global CRISPR Market is expected to grow from $268 million in 2015 and CAGR 43% for the forecasted period of 2015-2021. The gene editing technology has grown significantly in the last decade. The gene editing tools have become more accessible and cost effective which has enabled a thorough understanding of human genome. CRISPR (clustered regularly interspaced short palindromic repeats) is a new gene editing tool which has opened new doors for gene editing. This technology allows researchers to perform microsurgery on genes, precisely and easily, changing a DNA sequence at exact locations on a chromosome. The global market of CRISPR is expected to grow from $268 million in 2015 and CAGR 43% for the forecasted period of 2015-2021.

CRISPR market is expected to grow on the back of several drivers such as increased R&D expenditure on biotechnology, backed by venture capitals, increasing age related genetic disorders, increasing private and government expenditure on genetic research, high prevalence rate of genetic birth disorders and high demand of synthetic genes. Several factors such as limited awareness and little presence in emerging markets are restraints in the path of growth of the market.

The Global CRISPR market is segmented on the basis of application and end users: On the basis of application the market is segmented into Genome Editing, Genetic engineering, gRNA Database/Gene Library, CRISPR Plasmid and vectors so on. CRISPR Plasmid is the highest growing segment due to high demand among scientists and researchers. By end user, the market is segmented into Biotechnology companies, Pharmaceutical companies, Academic and research Institutes, Research and development institutes, Competitive Intelligence, Merger and Acquisitions and Innovation. In end user, the academic and research is highest growing segment due to high level of R&D into genome process, development of new drugs and development of genetically modified organisms and drugs.

The geography analysis consists of North America (US, Canada), Europe (United Kingdom, France, Germany, Spain, Italy), Asia Pacific (India, China, Japan) and Rest of the world. North America is the largest geographical market (2015) in CRISPR because high level of academies and research based in region. Asia-Pacific region is expected to grow at the fastest rate in forecasted period due to increase in number of contract research organization and emergence of drug discovery.

Major industry players in CRISPR market are: Editas Medicine (US), CRISPR therapeutics (Switzerland), GenScript USA Inc. (US), Horizon Discovery Group plc (UK), Integrated DNA Technologies, Inc. (US), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (US), OriGene Technologies, Inc. (US), Sangamo Biosciences, Inc. (US), Sigma-Aldrich Corporation (US), Thermo Fisher Scientific, Inc. (US), and Transposagen Biopharmaceuticals, Inc. (US).

1.    EXECUTIVE SUMMARY
1.1.    ESTIMATION METHODOLOGY
    
2.    MARKET OVERVIEW
2.1.    CRISPR- INTRODUCTION
2.2.    VALUE CHAIN ANALYSIS
2.3.    KEY BUYING CRITERIA
2.4.    RESEARCH AND DEVELOPMENT
2.4.1.    PATENT ANALYSIS
2.5.    CRISPR VS. CONVENTIONAL GENE EDITING TOOLS
2.5.1.    TALEN
2.5.2.    ZFN
2.6.    CRISPR: NOVEL INITIATIVES
2.6.1.    CRISPR CAS9 TECHNOLOGY
2.6.2.    CRISPR AS A GENE EDITING TOOL TO TREAT GENETIC DISORDERS
2.6.2.1.    GENE SURGERY
2.6.3.    CRISP AS A GENE EDITING TOOL IN DRUG DEVELOPMENT
2.7.    STRATEGIC RECOMMENDATION AND CONCLUSION
    
3.    SECTOR ANALYSIS
3.1.    GENE EDITING MARKET
    
4.    MARKET DETERMINANTS
4.1.    DRIVERS
4.1.1.    RISE IN DRUG DISCOVERY MARKET
4.1.2.    DEMAND FOR SYNTHETIC GENES
4.1.3.    HIGH PREVALENCE OF GENETIC BIRTH DISORDERS
4.1.4.    AGE RELATED GENETIC DISORDERS
4.1.5.    RISE IN THE HEALTHCARE RESEARCH AND DEVELOPMENT BUDGETS
4.1.6.    VENTURE CAPITAL
4.1.7.    GLOBAL INCREASE IN LIFE STYLE ORIENTED DISEASES & FATALITIES
4.1.8.    GMOS INCREASE CROP YIELDS AND PROMOTE EFFICIENT LAND USE
4.2.    RESTRAINTS
4.2.1.    ETHICAL ISSUES RELATED TO MISUSE OF CRISPR GENE EDITING TOOL
4.2.2.    LIMITED AWARENESS
4.2.3.    LIMITED PRESENCE IN EMERGING MARKETS
4.3.    OPPORTUNITIES
4.3.1.    CRISPR GENE EDITING CAN OPEN THE MARKET FOR GENE SURGERY.
4.3.2.    EMERGING CONTRACT RESEARCH MARKET IN ASIA
4.4.    CHALLENGES
4.4.1.    PATENT INFRINGEMENT
4.4.2.    PRESENCE OF ALTERNATIVE GENE EDITING TOOLS
    
5.    MARKET SEGMENTATION
5.1.    BY APPLICATION
5.1.1.    GENOME EDITING
5.1.2.    GENETIC ENGINEERING
5.1.3.    GRNA DATABASE/GENE LIBRARY
5.1.4.    CRISPR PLASMID
5.1.5.    HUMAN STEM CELLS
5.1.6.    GENETICALLY MODIFIED ORGANISMS/CROPS
5.1.7.    CELL LINE ENGINEERING
5.2.    BY END USER
5.2.1.    BIOTECHNOLOGY COMPANIES
5.2.2.    PHARMACEUTICAL COMPANIES
5.2.3.    ACADEMIC INSTITUTES
5.2.4.    RESEARCH AND DEVELOPMENT INSTITUTES
5.3.    COMPETITIVE INTELLIGENCE
5.3.1.    MERGER AND ACQUISITIONS
5.3.2.    INNOVATION
5.3.3.    VENTURE CAPITAL FUNDING
    
6.    GEOGRAPHICAL ANALYSIS
6.1.    NORTH AMERICA
6.1.1.    UNITED STATES
6.1.2.    CANADA
6.1.3.    RONA (REST OF NORTH AMERICA)
6.2.    EUROPE
6.2.1.    UNITED KINGDOM
6.2.2.    FRANCE
6.2.3.    GERMANY
6.2.4.    SPAIN
6.2.5.    ITALY
6.2.6.    ROE (REST OF EUROPE)
6.3.    ASIA PACIFIC
6.3.1.    CHINA
6.3.2.    JAPAN
6.3.3.    INDIA
6.4.    REST OF THE WORLD
6.5.    MIDDLE EAST AND AFRICA
6.5.1.    LATIN AMERICA
6.5.2.    BRAZIL
    
7.    COMPANY PROFILING
7.1.    THERMO FISHER SCIENTIFIC
7.2.    EDITAS MEDICINE
7.3.    CARIBOU BIOSCIENCES
7.4.    CRISPR THERAPEUTICS
7.5.    INTELLIA THERAPEUTICS, INC.
7.6.    CELLECTIS
7.7.    HORIZON DISCOVERY PLC
7.8.    SIGMA ALDRICH
7.9.    PRECISION BIOSCIENCES
7.10.    GENSCRIPT
7.11.    SANGAMO BIOSCIENCES INC.
7.12.    LONZA GROUP LIMITED
7.13.    INTEGRATED DNA TECHNOLOGIES
7.14.    NEW ENGLAND BIOLABS
7.15.    OREGENE TECHNOLOGIES
7.16.    TRANSPOSGENBIOPHRAMACEUTICALS
    
    
LIST    
1    GLOBAL CRISPR MARKET BY END USERS 2014-2023 ($ MILLION)
2    COMPARISON BETWEEN CRISPR, ZFN AND TALENS
3    VARIOUS INITIATIVES AND POLICIES UNDER TAKEN BY THE GOVERNMENT IN HEALTHCARE SECTOR
4    RISING PUBLIC HEALTH AND LONG-TERM CARE EXPENDITURE OVER THE NEXT DECADES
5    MAJOR CONCERNS RELATED WITH THE GENETIC ENGINEERING
6    GLOBAL AREA OF GENETIC MODIFIED CROP IN 2013 AND 2014 BY COUNTRIES (MILLION HECTARES)
7    GLOBAL CRISPR MARKET BY BIOTECH FIRMS 2014-2023 ($ MILLION)
8    GLOBAL CRISPR MARKET BY PHARMA COMPANIES 2014-2023 ($ MILLION)
9    GLOBAL CRISPR MARKET BY ACADEMIC INSTITUTIONS 2014-2023 ($ MILLION)
10    GLOBAL CRISPR MARKET BY RESEARCH FOUNDATION 2014-2023 ($ MILLION)
11    EUROPE CRISPR MARKET 2014-2023 ($ MILLION)
12    ASIA PACIFIC CRISPR MARKET 2014-2023 ($ MILLION)
13    GOVERNMENT ENTITIES ENTITLED FOR RESEARCH AND RESTRICTIONS UNDER TYPE 2 USAGE
    
FIGURES LIST    
1    NUMBER OF SCIENTIFIC PAPERS ON CRISPR (2012-2015)
2    GLOBAL CRISPR MARKET 2014-2023 ($ MILLION)
3    VALUE CHAIN ANALYSIS OF CRISPR MARKET
4    PATENT BY END USER
5    CAUSES OF DEATHS DURING 2014, WORLDWIDE
6    FATALITIES INCREASING DUE TO LIFE STYLE ORIENTED DISEASES (IN THOUSAND)
7    TOP REASONS A COMPANY OUTSOURCES DRUG DISCOVERY PROJECTS TO CRO’S
8    GLOBAL CRISPR MARKET BY GENOME EDITING 2014-2023 ($ MILLION)
9    GLOBAL CRISPR MARKET BY GENETIC ENGINEERING 2014-2023 ($ MILLION)
10    GLOBAL CRISPR MARKET BY GRNA DATABASE/GENE LIBRARY 2014-2023 ($ MILLION)
11    GLOBAL CRISPR MARKET BY CRISPR PLASMID AND VECTORS 2014-2023 ($ MILLION)
12    GLOBAL CRISPR MARKET BY HUMAN STEM CELL 2014-2023 ($ MILLION)
13    GLOBAL CRISPR MARKET BY GENETICALLY MODIFIED ORGANISMS/CROPS2014-2023 ($ MILLION)
14    GLOBAL CRISPR MARKET BY CELL LINE ENGINEERING 2014-2023 ($ MILLION)
15    GLOBAL CELL LINE DEVELOPMENT MARKET SHARE BY REGION, 2014
16    GLOBAL CRISPR MARKET BY END USER MARKET 2014-2023 ($ MILLION)
17    GLOBAL CRISPR MARKET BY BIOTECH FIRMS 2014-2023 ($ MILLION)
18    LEADING VENTURE CAPITAL FINANCED BIOTECHNOLOGY COMPANIES IN SWITZERLAND IN 2014, BY INVESTED AMOUNT ($ MILLION)
19    GLOBAL CRISPR MARKET BY PHARMA COMPANIES 2014-2023 ($ MILLION)
20    LIST OF TOP UNIVERSITIES AROUND THE WORLD FOR GENETIC ENGINEERING, 2015
21    GLOBAL CRISPR MARKET BY ACADEMIC INSTITUTIONS 2014-2023 ($ MILLION)
22    GLOBAL CRISPR MARKET BY RESEARCH FOUNDATION 2014-2023 ($ MILLION)
23    GLOBAL CRISPR MARKET COMPANIES SHARE 2014
24    GLOBAL CRISPR MARKET SHARE BY REGION IN 2015
25    NORTH AMERICA CRISPR MARKET 2014-2023 ($ MILLION)
26    ADOPTION OF GMO CROPS IN THE US IN 2014
27    NORTH AMERICA’S CRISPR MARKET SHARE IN 2015
28    GLOBAL PHARMACEUTICAL MARKET REVENUE DISTRIBUTION BY REGION IN 2014
29    US CRISPR MARKET 2014-2023 ($ MILLION)
30    REASONS FOR ADOPTING GENETICALLY ENGINEERED CROP (BT COTTON)
31    FUNDS ALLOCATED FOR RESEARCH ACTIVITIES IN BUDGET 2016
32    GM CROPS GROWN IN CANADA IN 2014
33    CANADA CRISPR MARKET 2014-2023 ($ MILLION)
34    RONA CRISPR MARKET 2014-2023 ($ MILLION)
35    EUROPE CRISPR MARKET 2014-2023 ($ MILLION)
36    UK CRISPR MARKET 2014-2023 ($ MILLION)
37    FRANCE CRISPR MARKET 2014-2023 ($ MILLION)
38    GERMANY CRISPR MARKET 2014-2023 ($ MILLION)
39    SPAIN CRISPR MARKET 2014-2023 ($ MILLION)
40    ITALY CRISPR MARKET 2014-2023 ($ MILLION)
41    REST OF EUROPE CRISPR MARKET 2014-2023 ($ MILLION)
42    CHINA CRISPR MARKET 2014-2023 ($ MILLION)
43    JAPAN CRISPR MARKET 2014-2023 ($ MILLION)
44    INDIA CRISP MARKET 2014-2023 ($ MILLION)
45    ROW CRISPR MARKET 2014-2023 ($ MILLION)
46    PHARMACEUTICAL MARKET SIZE FOR AFRICA ($ BILLION)
47    BRAZIL’S POSITION IN CULTIVATED GM CROP AREA

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion